ARCHIVES

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

This article is from The Cancer Letter archive.

Vol. 38 No. 18 | May 4, 2012

Download PDF Visit The Full Archive

Related Articles

House Committee Hits “Earmarks” For diseases; Broder Is Lectured On Occupational Exposures

May 21, 1993

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

Letters: Kopans To Broder: Response Ignores Major Questions

October 15, 1993

Reimbursement: NCI, VA Begin Project On Clinical Trials Access For Veterans

January 17, 1997

How the Institute Fared In House Markup: Chart

July 18, 1997

Lasker Official Urges Congressional Support Of NCI Bypass Budget

April 20, 1990